Biochemical Markers of Bone and Collagen Turnover in Acromegaly or Cushing's Syndrome
The DOI matches its Crossref record.
Abstract
We evaluated serum bone Gla-protein (osteocalcin, BGP), carboxyterminal propeptide of type I procollagen (PICP) and aminoterminal propeptide of type III procollagen (PIIINP) in 15 patients with active acromegaly (6M aged 27-54, 4 PMF aged 39-51, 5MP aged 54-65 years), 12 with active Cushing'S syndrome [(CS) 2M of 32 and 42 years; 4 PMF aged 25-40; 6MF aged 50-64)] and controls evenly matched for age, sex and menstrual status. Patients with acromegaly were evaluated before and at regular intervals on octreotide treatment (50-150 μg t.i.d., s.c.); the duration of the follow-up was 5-49 months (median 28). Endocrine evaluation included measurements of serum GH, IGF-I, BGP, PICP and PIIINP. In a case-control analysis, acromegalic patients showed increased BGP (14.3 ± 2.1 vs 8.3 ± 2.1 ng/ml p<0.001) and PIIINP concentrations (4.8 ± 1.4 vs 3.1 ± 0.7 μg/l, p<0.02). During octreotide treatment we observed a roughly parallel decline of GH, IGF-I and BGP. BGP and log-transformed 24-h mean GH concentrations were positively correlated (r = 0.48, p<0.001) as was the case for BGP and IGF-I (r = 0.43, p<0.001). Also PIIINP correlated with log-transformed GH (r = 0.58, p<0.001) and IGF-I (r = 0.35, p<0.05). Serum PICP did not differ in the two groups (152 ± 55 vs 120 ± 55 μg/1, NS) and did not correlate either with GH or IGF-I. Patients with CS were evaluated measuring serum and urinary cortisol (UFC), ACTH, BGP, PICP, PIIINP. They showed decreased levels of BGP (3.6 ± 2.4 vs 8.2 ± 3.2 ng/ml, p<0.01) and PIIINP (2.8 ± 0.8 vs 3.7 ± 0.8 μg/l, p<0.05), no differences were evident for PICP (128 ± 46 vs 117 ± 44 μg/1). A negative correlation was demonstrated between log-transformed cortisol (24-h mean) and log-transformed BGP (r = -0.60, p<0.05). No correlation was found among the other examined variables. The present study suggests that patients with active acromegaly have increased BGP and PIIINP levels, reflecting enhanced osteoblastic activity and soft tissue overgrowth respectively, that may be reverted by octreotide treatment. In patients with CS reduced levels of BGP and PIIINP and the inverse correlation between BGP and cortisol suggest an inhibitory effect of cortisol on osteoblastic activity and soft tissue collagen synthesis. The apparent discrepancy between BGP and PICP, both major osteoblastic products, could be due to different catabolic pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
Mazziotti, G., Biagioli, E., Maffezzoni, F., Spinello, M., Serra, V., Maroldi, R., Floriani, I., & Giustina, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2937 · Cited by 183
“We explored heterogeneity by a sensitivity analysis including only studies in active acromegaly patients (9, 13, 37, 39, 41, 47, 54).”
MethodMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Torlontano, M., Chiodini, I., Pileri, M., Guglielmi, G., Cammisa, M., Modoni, S., Carnevale, V., Trischitta, V., & Scillitani, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5856 · Cited by 91
Sartorio, A., Conti, A., Ferrero, S., Giambona, S., Re, T., Passini, E., & Ambrosi, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380146 · Cited by 84
Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome
Tóth, M., & Grossman, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12189 · Cited by 81
Skeletal involvement in adult patients with endogenous hypercortisolism
Chiodini, I., Torlontano, M., Carnevale, V., Trischitta, V., & Scillitani, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345601 · Cited by 78
Bolanowski, M., Daroszewski, J., Mędraś, M., & Zadrożna-Śliwka, B. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0649-9 · Cited by 74
“The bone turnover processes (resorption and formation) are closely related; IGF-1 is a possible coupling factor; and the stimulation of resorption, which occurs at the beginning, is followed by a bone formation increase later [20,21].”
BackgroundBone metabolism and mass in women with Cushing’s syndrome and adrenal incidentaloma
Francucci, C. M., Pantanetti, P., Garrapa, G. G., Massi, F., Arnaldi, G., & Mantero, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01602.x · Cited by 65
“In the present and other reports (Ekenstam et al ., 1988; Sartorio et al ., 1988b, 1996, 1998; Piovesan et al., 1994; Osella et al., 1997; Chiodini et al., 1998; Torlontano et al., 1999), with the exception of the study of Hermus et al. (1995), the levels of BGP, a marker of bone formation, are…”
Osella, G., Reimondo, G., Peretti, P., Alì, A., Paccotti, P., Angeli, A., & Terzolo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7178 · Cited by 54
Sereg, M., Tőke, J., Patócs, A., Varga, I., Igaz, P., Szücs, N., Horányi, J., Pusztai, P., Czirják, S., Gláz, E., et al. (2011) · Steroids · doi:10.1016/j.steroids.2010.08.007 · Cited by 53
Metadata
- Authors
- Piovesan, A., Terzolo, M., Reimondo, G., Pia, A., Codegone, A., Osella, G., Boccuzzi, A., Paccotti, P., & Angeli, A.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 1994-05
- Volume
- 26
- Issue
- 05
- Pages
- 234-237
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2032111961
- Cited by
- 58
- References
- 0
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.